Automobi Molecular Diagnostics

Automobi Molecular Diagnostics was a China-based molecular diagnostics joint venture formed by Mobidiag and Autobio Diagnostics to commercialize the Novodiag automated molecular diagnostics platform and selected infectious disease assays in Greater China. The company focused on rapid nucleic-acid-based testing for infectious diseases and antimicrobial resistance, leveraging real-time PCR and microarray-based workflows. Its early activities included regulatory registration with China\u2019s NMPA, local commercialization, and plans to establish local manufacturing for certain system components and disposables. Corporate registry data indicates the entity was later deregistered, suggesting it is no longer active as a standalone operating company.